ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Biomarkers in Chronic Airway Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00849836
Recruitment Status : Unknown
Verified February 2009 by Chonbuk National University.
Recruitment status was:  Recruiting
First Posted : February 24, 2009
Last Update Posted : February 24, 2009
Sponsor:
Information provided by:
Chonbuk National University

Brief Summary:

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Condition or disease
Asthma COPD

Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders
Study Start Date : February 2009
Estimated Study Completion Date : January 2010

Group/Cohort
Acute exacerbation
Stable disease
Healthy control




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects
Criteria

Inclusion Criteria:

  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00849836


Contacts
Contact: So Ri Kim, MD, PhD 82-63-250-2475 sori@chonbuk.ac.kr
Contact: Yong Chul Lee, MD, PhD 82-63-250-1664 leeyc@chonbuk.ac.kr

Locations
Korea, Republic of
Chonbuk National University Medical School Recruiting
Jeonju, Korea, Republic of, 561-180
Contact: So Ri Kim, MD, PhD       sori@chonbuk.ac.kr   
Contact: Yong Chul Lee, MD, PhD       leeyc@chonbuk.ac.kr   
Principal Investigator: Yong Chul Lee, MD, PhD         
Sub-Investigator: So Ri Kim, MD, PhD         
Sponsors and Collaborators
Chonbuk National University

Responsible Party: Yong Chul Lee, Chonbuk National University Medical School
ClinicalTrials.gov Identifier: NCT00849836     History of Changes
Other Study ID Numbers: RCPD
First Posted: February 24, 2009    Key Record Dates
Last Update Posted: February 24, 2009
Last Verified: February 2009